Related Experiment Videos
RhoG signals in parallel with Rac1 and Cdc42
Krister Wennerberg1, Shawn M Ellerbroek, Rong-Yu Liu
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599-7295, USA. krister@med.unc.edu
The Journal of Biological Chemistry
|October 12, 2002
Summary
RhoG, a small GTPase, signals independently of Rac1 and Cdc42. It utilizes a distinct set of downstream effectors, revealing novel RhoG signaling pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Signal Transduction
Background:
- RhoG is a Rho family GTPase with high sequence identity to Rac1 and Cdc42.
- Previous research suggested RhoG acts via Rac1 and Cdc42 activation.
Purpose of the Study:
- Investigate RhoG signaling mechanisms, including activation pathways.
- Elucidate downstream signaling properties and in vivo functional relationships with Rac1 and Cdc42.
Main Methods:
- In vitro activation assays using guanine nucleotide exchange factors (GEFs) like Vav2 and Dbs.
- GTP-dependent effector interaction studies.
- Analysis of downstream signaling targets (JNK, Akt, SRF, NF-kappaB).
- In vivo functional assays using dominant-negative Rac1.
Main Results:
- RhoG is activated by GEFs that also activate Rac/Cdc42, suggesting concurrent activation.
- RhoG interacts with a subset of Rac/Cdc42 effectors (IQGAP2, MLK-3, PLD1) in a GTP-dependent manner.
- Activated RhoG stimulates JNK and Akt, but not SRF or NF-kappaB.
- Activated RhoG induces lamellipodia independently of Rac1 activation.
Conclusions:
- RhoG signaling is not mediated by Rac1 or Cdc42 activation.
- RhoG directly utilizes a subset of common effectors for its functions.
- RhoG represents an independent signaling pathway within the Rho GTPase family.